ABOUT THIS PODCAST 🔗

Update frequency:
monthly
Average audio length:
31 minutes
Guest interviews
English
United States
16 episodes
since June 23, 2025
episodic

LATEST EPISODE 🔗

What if optimism is a competitive advantage? In this episode of Decoded, Dr. Jurgi Camblong sits down with Baroness Poppy Gustafsson CBE, co-founder of Darktrace and former UK Minister for Investment, to explore what it takes to lead at scale, how technology and government compare, and how Europe c…

SEARCH PAST EPISODES

Search past episodes of Decoded.

PREVIOUS EPISODES

What does it take for a 130-year-old company to remain at the forefront of pharmaceutical innovation? In this episode of Decoded, Dr. Jurgi Camblong sits down with André Hoffmann, Vice-Chair of Roche and the fourth generation of the Hoffmann family to lead the company since 1896, to discuss how gen…
What if AI's biggest threat is not a smarter machine, but a less curious human?In this episode of Decoded, Dr. Jurgi Camblong sits down with Pr. Joseph Sifakis, Turing Award laureate and inventor of model checking, the mathematical method that taught machines to prove their own correctness. Jo…
What if healthcare systems aren't broken — they're just built for the wrong job? In this episode of Decoded, Dr. Jurgi Camblong sits down with Lord David Prior, who spent years running the NHS from the inside, to explore why shifting from sick care to health care — powered by AI and data-…
What does it take to ask one question — *how do you free software from hardware?* — and end up reshaping the entire computing industry? In this episode of Decoded, Dr. Jurgi Camblong speaks with Edouard Bugnion, co-founder of VMware and Vice President for Innovation and Impact at EPFL, the Swiss Fe…
What does it take to turn a two-person startup in Paris into a $6.8 billion exit, and then do it all over again for 200 other founders?In this episode of Decoded, Dr. Jurgi Camblong speaks with Bernard Liautaud, co-founder of BusinessObjects and Managing Partner at Balderton Capital, one of Europe&…
What happens when a world-class biologist decides that academic research isn't moving fast enough for patients? Dr. Keith Flaherty is a physician, scientist, and founder who obsesses over the "wiring of cells". As the Director of Clinical Research at the Mass General Hospital Cancer …
What happens when the mind behind the Mars Rovers turns its attention to fighting cancer and developing next-generation medicines?Today, Thomas Fuchs is the Chief AI Officer at Eli Lilly & Company, but he started his career at NASA, building the AI that helped rovers navigate the surface of Mar…
Most doctors look at a tumor and see a disease. Professor Olivier Michielin sees a code waiting to be cracked. Starting his career in physics and training under Nobel Prize winner Martin Karplus, Olivier realized early on that he "would not be happy just talking to electrons". He pivoted …
Are we practicing healthcare, or just "sick care"?In this episode of Decoded, Jurgi Camblong sits down with Dr. Michael Snyder, Chair of Genetics at Stanford Medicine and one of the most cited scientists in the world, to challenge the status quo of modern medicine.We monitor our cars with…
Disclaimer: The podcast and artwork embedded on this page are from Dr. Jurgi Camblong, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.